[4-(2-CHLORO-6-METHYLAMINO-PURIN-9-YL-METHYL)-7-(DIETHOXY-PHOSPHORYL)-HEPTYL]-PHOSPHONIC-ACID-DIETHYLESTER
Compound with spectra: 1 NMR
![[4-(2-CHLORO-6-METHYLAMINO-PURIN-9-YL-METHYL)-7-(DIETHOXY-PHOSPHORYL)-HEPTYL]-PHOSPHONIC-ACID-DIETHYLESTER](/api/compound/IUcC5WOr0jN.png?ph=true&h=300&w=458 "[4-(2-CHLORO-6-METHYLAMINO-PURIN-9-YL-METHYL)-7-(DIETHOXY-PHOSPHORYL)-HEPTYL]-PHOSPHONIC-ACID-DIETHYLESTER")
| SpectraBase Compound ID | IUcC5WOr0jN |
|---|---|
| InChI | InChI=1S/C22H40ClN5O6P2/c1-6-31-35(29,32-7-2)14-10-12-18(13-11-15-36(30,33-8-3)34-9-4)16-28-17-25-19-20(24-5)26-22(23)27-21(19)28/h17-18H,6-16H2,1-5H3,(H,24,26,27) |
| InChIKey | IFIKDQIOWDBKBD-UHFFFAOYSA-N |
| Mol Weight | 568.0 g/mol |
| Molecular Formula | C22H40ClN5O6P2 |
| Exact Mass | 567.214236 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | Unknown |
[3-(2-CHLORO-6-METHYLAMINO-PURIN-9-YL)-2-PHOSPHONO-METHYL-PROPYL]-PHOSPHONIC-ACID
[3-(2-CHLORO-6-METHYLAMINO-PURIN-9-YL)-2-PHOSPHONO-METHYL-PROPYL]-PHOSPHONIC-ACID-SODIUM-SALT
CARBONIC-ACID-3-(2-CHLORO-6-METHYLAMINO-PURIN-9-YL)-2-PHOSPHONOOXY-METHYL-PROPYLESTER-ETHYLESTER-AMMONIUM-SALT
2-AMINO-9-BETA-CYANOETHYL-6-PHENYLAMINO-PURINE
Diisopropyl{2-[2-amino-6-(n-propylamino)-9H-purine-9-yl]ethoxy}methyl-phosphonate
(R)-2,6-Diamino-9-[3'-fluoropropyl-2'-(diisopropylphosphonomethoxy)]purine
Dibenzyl-[2'-chloro-9'-methyl-9H-purin-6'-yl]-amine
6-Amino-9-(2-hydroxy-propyl)-2-phenylpurine
(R)-2-Amino-6-chloro-9-[2'-(diisopropylphosphonyl)methoxy-3'-fluoropropyl]purine
9H-Purine-9-propanoic acid, .alpha.-amino-6-[[3-methyl-4-[(trimethylsilyl)oxy]-2-butenyl]amino]-, trimethylsilyl ester, [S-(E)]-
| Title | Journal or Book | Year |
|---|---|---|
| Acyclic Analogues of Adenosine Bisphosphates as P2Y Receptor Antagonists: Phosphate Substitution Leads to Multiple Pathways of Inhibition of Platelet Aggregation | Journal of Medicinal Chemistry | 2002 |